2026-01-19 - Analysis Report
### Company Overview
Lam Research is a leading provider of semiconductor processing and packaging equipment.

### Return Rate Comparison

* Cumulative Return of Review Stock: **187.79%**
* Cumulative Return of Comparison Stock (S&P 500, VOO): **82.54%**
* Degree of Divergence (max: N/A, min: N/A, current: N/A, relative divergence: N/A)

The review stock has outperformed the S&P 500 index by a large margin, with a cumulative return rate of 187.79% compared to 82.54%.

### Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|--------|
| 2016-2018  | 0.0% | 15.7% | 0.0% | 1.6 | 17.2B  |
| 2017-2019  | 34.0% | 15.7% | 25.0% | 1.7 | 36.9B  |
| 2018-2020  | 63.0% | 25.9% | 42.0% | 1.5 | 59.5B  |
| 2019-2021  | 77.0% | 25.9% | 40.0% | 1.6 | 90.7B  |
| 2020-2022  | 12.0% | 33.3% | 2.0% | 1.6 | 53.0B  |
| 2021-2023  | -3.0% | 33.3% | -19.0% | 1.8 | 98.8B  |
| 2022-2024  | -16.0% | 27.7% | -42.0% | 1.9 | 91.1B  |
| 2023-2025  | 52.0% | 35.7% | 3.0% | 2.0 | 215.9B |

### Recent Stock Price Fluctuations
* Close: **$222.96**
* Last-market: {'price': 222.96, 'previousClose': 217.47, 'change': 2.52}
* 5-day SMA: **$216.80**
* 20-day SMA: **$192.84**
* 60-day SMA: **$168.56**

The stock has experienced a slight rebound, with a 5-day moving average still below the current price.

### RSI, PPO Index Indicators

* Market Risk Indicator (MRI): **0.80** (High Investment Recommended)
* RSI: **73.91**
* PPO: **0.94**
* Buy: Cash 0%
Risk Level: Medium
Recent (20 days) relative divergence change: **0.0** (flat)
7-day Rank change: **0** (flat)
7-day Dynamic Expected Return change: **0.0** (flat)

### Recent News & Significant Events
* [2026-01-15] What Makes Lam Research (LRCX) a Strong Momentum Stock: Buy Now? - Nasdaq (news.google.com)
* [2026-01-15] Why Lam Research (LRCX) Stock Is Trading Up Today - Yahoo Finance (news.google.com)
* [2026-01-18] Sen. Markwayne Mullin Buys Lam Research Corporation (NASDAQ:LRCX) Stock - MarketBeat (news.google.com)
* [2026-01-15] Lam Research Soars 165% in a Year: Is LRCX Stock Still a Buy? - Zacks Investment Research (news.google.com)
* [2026-01-02] The Memory Market Is Going to Boom in 2026: 1 Top Stock to Buy Hand Over Fist Before It Skyrockets (Hint: It's Not Micron) - The Motley Fool (news.google.com)
* [2026-01-18] Analysts bullish on Lam Research Corporation (LRCX) as semiconductor capex and memory investments rise - MSN (news.google.com)

### Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.72 (~Buy)
- Opinions: 31
- Target Price (avg/high/low): 199.35 / 265.00 / 115.00
```

### Recent Earnings Analysis
| Date | EPS | Revenue |
|-----:|----:|---------|
| 2025-10-24 | 1.24 | $5.32B  |
| 2025-04-25 | 1.04 | $4.72B  |
| 2025-01-31 | 0.93 | $4.38B  |
| 2024-10-28 | 0.86 | $4.17B  |
| 2025-10-24 | 0.86 | $4.17B  |

### Financial Information

#### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $5.32B  | 50.43%      |
| 2025-06-30 | $5.17B  | 50.08%      |
| 2025-03-31 | $4.72B  | 49.02%      |
| 2024-12-31 | $4.38B  | 47.37%      |
| 2024-09-30 | $4.17B  | 48.05%      |

#### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $10.19B | 15.39% |
| 2025-06-30 | $9.86B  | 17.44% |
| 2025-03-31 | $9.51B  | 13.99% |
| 2024-12-31 | $8.81B  | 13.52% |
| 2024-09-30 | $8.47B  | 13.18% |

### Comprehensive Analysis

Lam Research has experienced significant growth, with a cumulative return rate of 187.79% compared to the S&P 500 index's 82.54%. The stock's alpha and beta values have fluctuated, but generally indicate a moderate level of risk. The RSI and PPO index indicators suggest a buy signal, while the Market Risk Indicator recommends a high level of investment. Recent news and significant events have highlighted the company's strengths in the semiconductor industry. Analyst opinions are generally positive, with a buy consensus and target prices ranging from $115.00 to $265.00.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.